ASO Author Reflections: Palliative Management of Peritoneal Metastasis Exploring the Risks and Benefits of CRS/HIPEC, a Distinctly Different Context Than Early CRS/HIPEC Intervention With 'Curative Intent'.
作者信息
Foster Jason M, Zhang Chunmeng
机构信息
Division of Surgical Oncology, Department of Surgery, University of Nebraska Medical Center, Omaha, NE, USA.
出版信息
Ann Surg Oncol. 2022 May;29(5):3347-3348. doi: 10.1245/s10434-022-11377-8. Epub 2022 Feb 25.
PMID:35217972
Abstract
摘要
相似文献
1
ASO Author Reflections: Palliative Management of Peritoneal Metastasis Exploring the Risks and Benefits of CRS/HIPEC, a Distinctly Different Context Than Early CRS/HIPEC Intervention With 'Curative Intent'.ASO作者反思：腹膜转移的姑息治疗——探索CRS/HIPEC的风险与益处，这与具有“治愈意图”的早期CRS/HIPEC干预背景截然不同。
Ann Surg Oncol. 2022 May;29(5):3347-3348. doi: 10.1245/s10434-022-11377-8. Epub 2022 Feb 25.
2
ASO Author Reflections: Pathologic Response Ratio (PRR) in CRS and HIPEC for Peritoneal Metastasis from Colorectal Cancer.ASO作者反思：结直肠癌腹膜转移的CRS和HIPEC中的病理反应率（PRR）
Ann Surg Oncol. 2021 Dec;28(13):9148-9149. doi: 10.1245/s10434-021-10369-4. Epub 2021 Jun 27.
3
ASO Author Reflections: HIPEC Immunogenic Changes Could be Further Exploited by Immunotherapy to Treat Peritoneal Metastases from Colorectal Cancer.ASO作者反思：热灌注化疗的免疫原性变化可通过免疫疗法进一步利用，以治疗结直肠癌的腹膜转移。
Ann Surg Oncol. 2023 May;30(5):2664-2665. doi: 10.1245/s10434-023-13254-4. Epub 2023 Feb 17.
4
Treatment of Isolated Peritoneal Recurrences in Patients with Colorectal Peritoneal Metastases Previously Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.结直肠腹膜转移患者经细胞减灭术和腹腔热灌注化疗治疗后孤立性腹膜复发的治疗。
Ann Surg Oncol. 2018 Jul;25(7):1992-2001. doi: 10.1245/s10434-018-6423-8. Epub 2018 Apr 18.
5
ASO Author Reflections: If Once Is Good, Is Twice Just as Good? A critical evaluation of Repeat CRS-HIPEC for Colorectal Peritoneal Metastases.ASO作者反思：一次有益，两次是否同样有益？对复发性CRS-HIPEC治疗结直肠癌腹膜转移的批判性评估
Ann Surg Oncol. 2021 Sep;28(9):5339-5340. doi: 10.1245/s10434-021-09704-6. Epub 2021 Feb 18.
6
Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy in the Management of Colorectal Peritoneal Metastasis.细胞减灭术与热灌注腹腔内化疗在结直肠癌腹膜转移治疗中的应用
Surg Clin North Am. 2017 Jun;97(3):671-682. doi: 10.1016/j.suc.2017.01.013.
7
ASO Author Reflections: Addressing Hospital-Based Disparities in Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) and Survival in Patients with Isolated Colorectal Peritoneal Metastases.ASO作者反思：解决基于医院的孤立性结直肠腹膜转移患者在接受细胞减灭术联合热灌注化疗（CRS-HIPEC）及生存方面的差异问题。
Ann Surg Oncol. 2024 Jun;31(6):3787-3788. doi: 10.1245/s10434-024-15193-0. Epub 2024 Mar 18.
8
ASO Author Reflections: One Size Does Not Fit All-Enhanced Recovery After Surgery in CRS-HIPEC.ASO作者反思：一刀切并不适用于所有情况——结直肠癌合并腹腔热灌注化疗术后的加速康复。
Ann Surg Oncol. 2024 Aug;31(8):5400-5401. doi: 10.1245/s10434-024-15427-1. Epub 2024 May 24.
9
ASO Author Reflections: Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma treated with CRS-HIPEC.ASO作者反思：采用CRS-HIPEC治疗的弥漫性恶性腹膜间皮瘤的围手术期全身化疗
Ann Surg Oncol. 2024 Apr;31(4):2511-2512. doi: 10.1245/s10434-023-13768-x. Epub 2024 Jan 13.
10
Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience.结直肠癌和阑尾腺癌腹膜转移患者行完全细胞减灭术和腹腔热灌注化疗后复发部位：一项三级中心经验。
Ann Surg Oncol. 2019 Feb;26(2):482-489. doi: 10.1245/s10434-018-6860-4. Epub 2018 Dec 11.
Zotero 插件